8-K filing — Abacus Global Management, Inc. (ABXL)
Filed: 2026-08-24 AccNo: 0001628280-26-058671 Size: 1 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
Filed: 2026-08-13 AccNo: 0001628280-26-056792 Size: 207 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-08-24 AccNo: 0001628280-26-058671 Size: 1 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarA U.S. District Court unsealed documents in litigation between Coventry and Abacus Global Management revealing that Abacus knowingly relied on significantly underestimated life expectancy data from Lapetus Solutions and misled investors about a Lewis & Ellis valuation report. Lapetus showed a 41.5% actual-to-expected mortality ratio compared to industry standards near 100%, and Abacus allegedly manipulated the Lewis & Ellis report by using different discount rates and withholding life expectancy estimates to inflate portfolio valuations.
Read original at globenewswire-incAbacus Global Management (NYSE: ABX) announced it will release its second quarter 2026 financial results on August 6, 2026, followed by a conference call at 5:00 pm ET. The company will provide a live webcast on its investor relations website.
Read original at globenewswire-incAbacus Global Management stock rose 1.52% on Monday following news that the alternative asset management company successfully upsized its syndicated credit facility by $75 million to $225 million total, demonstrating strong financial management. The company also announced the planned retirement of board member Sean McNealy, who will transition to an advisory role.
Read original at the-motley-fool